Innovative Inhalation Devices With Digital Health Features Driving The COPD And Asthma Devices Market Trend: A Crucial Influence on the Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market's Transformation in 2025

"How Are the key drivers contributing to the expansion of the chronic obstructive pulmonary disease (copd) and asthma devices market?
The escalating incidence of respiratory ailments is predicted to fuel the expansion of the market for chronic obstructive pulmonary disease (COPD) and asthma devices. These respiratory conditions that include disease like asthma, COPD, pneumonia, and lung cancer, impact the lungs and respiratory system, affecting breathing and overall respiratory function. This surge in respiratory diseases is attributed to the rise in air pollution, shifts in climate patterns disrupting allergens and pathogens, and lifestyle behaviors such as smoking that jeopardize respiratory health. Devices for COPD and asthma are pivotal in the overall control and treatment of respiratory diseases, assisting patients in improving their respiratory health and uplift their general wellness. For example, the World Health Organization (WHO), a Switzerland-based specialized branch of the United Nations that tackles global public health, reported in March 2023 that COPD was the third primary cause of death worldwide, resulting in close to 3.23 million deaths. Moreover, nearly 90% of these deaths among individuals younger than 70 unfolded in low- to middle-income countries (LMICs). Hence, the escalating prevalence of respiratory diseases stimulates the expansion of the COPD and asthma device markets.

Get Your Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Report Here:
https://www.thebusinessresearchcompany.com/report/chronic-obstructive-pulmonary-disease-copd-and-asthma-devices-global-market-report

What growth opportunities are expected to drive the chronic obstructive pulmonary disease (copd) and asthma devices market's CAGR through 2034?
There has been a robust growth in the market size of chronic obstructive pulmonary disease (COPD) and asthma devices in past few years. The market is projected to grow from a value of $44.95 billion in 2024 to a substantial $47.83 billion in 2025, registering a compound annual growth rate (CAGR) of 6.4%. Factors like the growing elderly population, a rise in allergies incidences, more government initiatives, increased clinical research and trials, and a surge in urbanization have contributed to the historical growth.

In the upcoming years, the market for devices treating chronic obstructive pulmonary disease (COPD) and asthma is predicted to experience substantial growth, eventually reaching a valuation of $60.53 billion in 2029, reflecting a compound annual growth rate (CAGR) of 6.1%. The projected growth can be attributed to factors such as the increasing incidence of respiratory diseases, growing cigarette consumption, escalating environmental pollution and breathing issues, rising prevalence of respiratory illnesses, increasing health care spending, and the growing portability of drug delivery devices. The forecast period is expected to see dominant trends including technological progression, smart technology integration, tailored medication, the use of biological products, and the adoption of wearable respiratory monitors.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18298&type=smp

What are the emerging trends shaping the future of the chronic obstructive pulmonary disease (copd) and asthma devices market?
Firms dominating the market for devices addressing chronic obstructive pulmonary disease (COPD) and asthma are prioritizing the creation of inventive technologies like inhalation devices. These are planned to include digital health capabilities for distance monitoring and personalized therapeutic management. Inhalation devices, which deliver medications straight to the lungs, are such an example. Alkem Laboratories, a pharmaceutical firm based in India, debuted the Innohaler, a device that uses dry powder, in May 2022. This was aimed at improving the quality of life for COPD and asthma sufferers. The Innohaler employs cutting-edge breath-actuated technology, ensuring each inhalation accurately delivers the necessary medication, optimizing the dose, and minimizing waste. Its ergonomic design facilitates easy usage with an intuitive interface that can be operated by anyone, regardless of age. It is also compact and easy to carry around, which increases its portable advantages and bolsters patient compliance to prescribed procedures.

Which growth-oriented segments of the chronic obstructive pulmonary disease (copd) and asthma devices market are leading the industry's development?
The chronic obstructive pulmonary disease (COPD) and asthma devices market covered in this report is segmented -

1) By Type: Metered Dose Inhalers, Drug Powder Inhalers, Soft Mist Inhalers, Jet Nebulizers, Ultrasonic Nebulizers, Other Types
2) By Indication: Asthma, Chronic Obstructive Pulmonary Disease
3) By Application: Hospitals, Clinics, Home Care Settings, Research Institutions, Other Applications
4) By End User: Pediatric, Adult, Geriatric

Subsegments:
1) By Metered Dose Inhalers: Conventional MDI, Breath-Actuated MDI
2) By Drug Powder Inhalers: Dry Powder Inhalers (DPI), Multi-Dose DPI
3) By Soft Mist Inhalers: Respimat Soft Mist Inhalers, Other Soft Mist Devices
4) By Jet Nebulizers: Pneumatic Nebulizers, Venturi-Type Nebulizers
5) By Ultrasonic Nebulizers: Tabletop Ultrasonic Nebulizers, Portable Ultrasonic Nebulizers
6) By Other Types: Nebulizer Accessories, Spacer Devices

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18298

North America was the largest region in the chronic obstructive pulmonary disease (COPD) and asthma devices market in 2023. The regions covered in the chronic obstructive pulmonary disease (COPD) and asthma devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What companies are at the forefront of innovation in the chronic obstructive pulmonary disease (copd) and asthma devices market?
Major companies operating in the chronic obstructive pulmonary disease (COPD) and asthma devices market are AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc, 3M Health Care, Boehringer Ingelheim, Royal Philips NV, Teva Pharmaceuticals Industries Ltd., Baxter International Inc., Omron Corporation, Smiths Medical Inc., Recipharm AB, Cipla Ltd., Teleflex Incorporated, Chiesi Farmaceutici SpA, Lincre Holdings Inc., Sunovion Pharmaceuticals Inc., Verona Pharma plc, Drive DeVilbiss Healthcare, Pari Respiratory Equipment Inc., Allied Healthcare Products Inc., Clement Clarke International Ltd., Cohero Health Inc., Pneuma Respiratory Inc., Mundipharma International Ltd.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=18298&type=smp

What Is Covered In The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Global Market Report?

•Market Size Forecast: Examine the chronic obstructive pulmonary disease (copd) and asthma devices market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the chronic obstructive pulmonary disease (copd) and asthma devices market for a structured understanding.
•Key Players Overview: Analyze major players in the chronic obstructive pulmonary disease (copd) and asthma devices market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the chronic obstructive pulmonary disease (copd) and asthma devices market.
•Segment Contributions: Evaluate how different segments drive overall growth in the chronic obstructive pulmonary disease (copd) and asthma devices market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the chronic obstructive pulmonary disease (copd) and asthma devices market.
•Industry Challenges: Identify potential risks and obstacles affecting the chronic obstructive pulmonary disease (copd) and asthma devices market.
•Competitive Landscape: Review strategic developments in the chronic obstructive pulmonary disease (copd) and asthma devices market, including expansions, agreements, and new product launches.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.